M3, Inc. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2018; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2019
October 25, 2018 at 07:00 am
Share
M3, Inc. reported consolidated earnings results for the six months ended September 30, 2018. For the six months, the company's net sales were JPY 53,275 million compared to JPY 42,849 million a year ago. Operating profit was JPY 13,875 million compared to JPY 12,162 million a year ago. Net profit was JPY 9,626 million compared to JPY 8,029 million a year ago. Basic earnings per share was JPY 13.15 compared to JPY 11.42 a year ago. Diluted earnings per share was JPY 13.14 compared to JPY 11.42 a year ago.
The company provided consolidated earnings guidance for the year ending March 31, 2019. For the year, the company expects net sales of JPY 113,350 million, operating profit of JPY 31,720 million, net profit of JPY 22,220 million, and basic earnings per share of JPY 32.36.
M3, Inc. specializes in the provision of online services dedicated to the health field. Net sales (before intra-group eliminations) break down by activity as follows:
- medical marketing support services (40.3%): services enabling doctors and health professionals to search for medical resources, use the latest medical news, exchange opinions, learn about medical products and services and career development, etc. via m3.com., MR-kun, MDLinx and MEDI: GATE;
- support services to medical institutions (16.5%):
- clinical trial related services (10.7%): clinical trial support and clinical trial operations management services;
- human resources services (6.6%);
- other (1.6%): including marketing assistance and surveys of affiliated medical companies via specialized sites.
The balance of sales (24.3%) concerns international activities.
M3, Inc. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2018; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2019
M3, INC. 
